Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Stine Dahl Vest
  • Sarah E Coupland
  • Bita Esmaeli
  • Paul T Finger
  • Gerardo F Graue
  • Hans E Grossniklaus
  • Tine Gadegaard Hindso
  • Frederik Holm
  • Santosh G Honavar
  • Jwu Jin Khong
  • Marina Knudsen Kirkegaard
  • Penelope A McKelvie
  • Kaustubh Mulay
  • Peter Kristian Rasmussen
  • Matthew C Sniegowski
  • Bradley A Thuro
  • Geeta K Vemuganti

AIMS: To examine whether the specific location of ocular adnexal lymphoma (OAL) and the American Joint Committee on Cancer (AJCC) TNM tumour stage are prognostic factors for mortality in the main OAL subtypes.

METHODS: Clinical and survival data were retrospectively collected from seven international eye cancer centres. All patients from 1980 to 2017 with histologically verified primary or secondary OAL were included. Cox regression was used to compare the ocular adnexal tumour locations on all-cause mortality and disease-specific mortality.

RESULTS: OAL was identified in 1168 patients. The most frequent lymphoma subtypes were extranodal marginal zone B-cell lymphoma (EMZL) (n=688, 59%); follicular lymphoma (FL) (n=150, 13%); diffuse large B-cell lymphoma (DLBCL) (n=131, 11%); and mantle cell lymphoma (MCL) (n=89, 8%). AJCC/TNM tumour-stage (T-stage) was significantly associated with disease-specific mortality in primary ocular adnexal EMZL and increased through T-categories from T1 to T3 disease. No associations between AJCC/TNM T-stage and mortality were found in primary ocular adnexal FL, DLBCL, or MCL. EMZL located in the eyelid had a significantly increased disease-specific mortality compared with orbital and conjunctival EMZL, in both primary EMZL and the full EMZL cohort. In DLBCL, eyelid location had a significantly higher disease-specific mortality compared with an orbital or lacrimal gland location.

CONCLUSION: Disease-specific mortality is associated with AJCC/TNM T-stage in primary ocular adnexal EMZL patients. Lymphoma of the eyelid has the highest disease-specific mortality in primary EMZL, and in the full cohort of EMZL and DLBCL patients.

OriginalsprogEngelsk
TidsskriftBritish Journal of Ophthalmology
ISSN0007-1161
DOI
StatusE-pub ahead of print - 2022

Bibliografisk note

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 306197128